Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Check out some of our latest original content that was created and distributed as part of our ongoing collaborations with IR firms and other companies.

MissionIRNewsBreaks – AI-Driven Lending: FAVO Capital Inc. (FAVO) Sets New Standard in Funding Solutions for SMBs

FAVO Capital (OTC: FAVO) is a rapidly growing private credit company dedicated to providing fast, efficient, and personalized funding solutions for small and medium-sized businesses (“SMBs”). “FAVO Capital has more than $138 million in total funding supporting more than 10,000 businesses. The company leverages artificial intelligence (‘AI’)-powered analytics to provide faster, smarter funding decisions,” reads a recent article. “Publicly listed and regulated, FAVO Capital is committed to transparency and investor confidence. The company has expanded its market reach, currently operating in 45 states and the Dominican Republic. FAVO’s fast, flexible financing can result in funding delivered within hours, as it executes on its strategic expertise combined with cutting-edge fintech solutions.”

To view the full article, visit https://ibn.fm/6w4aN

About FAVO Capital Inc.

FAVO Capital is a rapidly growing alternative finance company headquartered in Fort Lauderdale, Florida. The company offers personalized alternative finance solutions to emerging, small and medium-sized businesses. “FAVO” is “Honeycomb” in Latin – The Honeycomb (Hexagon) is the most efficient shape in the universe. FAVO intends to be efficient, flexible and durable. For more information visit www.FavoCapital.com.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/FAVO

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in FAVO Capital Inc. FAVO | Leave a comment

Nutriband Inc. (NASDAQ: NTRB): A Relentless Mission Rooted in Purpose, Innovation, and Shareholder Value

  • NTRB listed on the Nasdaq in 2021, is trading above its IPO price, and hit an all-time high of $11.78 in January of this year
  • Nutriband’s AVERSA abuse-deterrent patch technology is FDA-bound and could command a market potential as high as $800 million annually

Serguei Melnik, Founder and President of Nutriband (NASDAQ: NTRB), recently joined The Smart Money Circle Show, where he pulled back the curtain on his no-nonsense approach to biotech entrepreneurship. His grounded tone and unwavering focus on long-term value stand in stark contrast to the conventional biotech playbook.

As is typical, the topic of the article focused on Nutriband’s history, technology, and vision. To that point, Nutriband’s core innovation is AVERSA, an abuse-deterrent technology designed to prevent the oral misuse of transdermal patches, particularly fentanyl, which can be 100 times more potent than heroin. The AVERSA system embeds ultra-bitter and ultra-spicy components that, in Melnik’s words, make it “almost impossible for abuse or misuse.” In short, risk of abuse is greatly reduced considering in order to ingest a drug like fentanyl, it will be accompanied by a taste akin to Bitrex meeting Pepper X, a real breakthrough in drug safety.

Adult misuse is one thing, but there is also a very real threat of potential death to children who unknowingly are exposed to residual amounts of fentanyl on patches.

The technology is now patented in more than 45 countries, and Nutriband is partnered with Kindeva Drug Delivery to commercialize new products. The company sees the next major milestone as an FDA submission seeking to bring the product to market.

According to Health Advances, the initial market opportunity for abuse-deterrent fentanyl patches could be between $80–$200 million in the first year of launch. If the FDA mandates such technologies, Melnik estimates the opportunity could swell to $800 million annually. Beyond fentanyl, AVERSA is a platform technology that could be adapted for other pain medications, creating multiple commercial pathways.

Doing It Differently from the Start

Unlike most biotech companies that go public with bloated capital raises, Nutriband went public via a Form 10 filing, handling even the legal work in-house with minimal funds. When bankers offered them tens of millions of dollars early on, Melnik walked away, believing it would ultimately destroy shareholder value. He cites peers who accepted similar terms and are now trading at fractions of their former selves – if they’re still trading at all. Meanwhile, Nutriband continues to trade above its IPO price and even hit an all-time high of $11.78 in January.

Outsmarting the Market and Protecting Shareholders

Melnik spoke candidly about how he witnessed the tactics of Wall Street firsthand. He shared a striking story of how market manipulators seemingly used company news against them. After observing suspicious trading patterns, Nutriband began keeping developments under wraps. In one example, when a patent was quietly announced in late 2021, shares surged from $3 to $10.44 on nearly 150 million shares of volume, the most active stock on Nasdaq that day. The lesson: silence can sometimes protect momentum.

Rather than fight Wall Street games, Melnik and his team took a different route to preserve capital. In 2022, the entire executive team took a 50% pay cut, saving $600,000 and extending their runway by over two years. That financial discipline attracted long-term allies, including a billionaire new investor, who has been very supportive of the company as it nears FDA submission for its flagship product.

Beyond Biotech: Diversified Revenue Streams and Transdermal Expertise

Unlike most early-stage biotech companies, Nutriband generates revenue today. The company operates a manufacturing facility in North Carolina that produces the Active Intelligence tape used by Reebok, among others. They also recently launched a mosquito-repelling patch, now approved for sale in Costa Rica. Melnik and his team personally tested the product by trekking through the Talamanca Mountain range without a single mosquito bite in four days.

Transdermal expertise is Nutriband’s hallmark, and Melnik is as committed as ever. “We only try to control what we can control,” he said. “If Wall Street funds don’t understand that we’re not coming back to them, I don’t know what else will make them.”

Leadership That Puts People First

Melnik isn’t just a President; he’s a founder with skin in the game, having tested products himself and taken financial hits to keep the company alive. Yet when asked in the podcast to share advice with his younger self, he didn’t talk about business plans or capital raises. He spoke about family and time.

His grounded mindset, passion for innovation, and unwillingness to compromise on shareholder value position Nutriband as a rare biotech story, one led by integrity, resilience, and vision that is nearing some critical milestones that could serve as significant catalysts to corporate value.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Nutriband Inc. NTRB | Leave a comment

MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Announces $10 Million Private Placement to Advance Louisiana SMC Project

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) has entered into an engagement with Red Cloud Securities Inc. for a “best efforts” private placement of up to $10 million in units priced at $1.20 each, with an option to raise an additional $1.5 million. Each unit includes one common share and one-half of a warrant exercisable at $1.75 for 36 months. Net proceeds will fund key initiatives related to Ucore’s planned Strategic Metals Complex in Louisiana, including securing feedstock and customer agreements, advancing engineering plans, and fulfilling obligations with the U.S. Department of Defense and Natural Resources Canada. The offering is set to close on or about June 19, 2025, pending necessary approvals.

To view the full press release, visit https://ibn.fm/QWupF

About Ucore Rare Metals Inc.

Ucore is focused on rare- and critical-metal resources, extraction, beneficiation, and separation technologies with the potential for production, growth, and scalability. Ucore’s vision and plan is to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry.

Through strategic partnerships, this plan includes disrupting the People’s Republic of China’s control of the North American REE supply chain through the near-term establishment of a heavy and light rare-earth processing facility in the U.S. State of Louisiana, subsequent Strategic Metal Complexes in Canada and Alaska and the longer-term development of Ucore’s 100% controlled Bokan-Dotson Ridge Rare Heavy REE Project on Prince of Wales Island in Southeast Alaska, USA.

Ucore is listed on the TSXV under the trading symbol “UCU” and in the United States on the OTC Markets’ OTCQX(R) Best Market under the ticker symbol “UURAF.”

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Develop 6.9 MW Community Solar Project in Nova Scotia

  • SolarBank has announced it will develop a 6.9 MW Brooklyn solar project, located in Nova Scotia and expected to power approximately 900 homes, under Canada’s first Community Solar Program.
  • The initiative supports Nova Scotia’s target of 80% renewable energy by 2030 and net-zero emissions by 2035.
  • AI Renewable Fund owns the project; SolarBank serves as developer and builder.
  • Construction is scheduled to begin in Spring 2026 and complete by Summer 2026, with total development cost estimated at $13.9 million.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced its role as developer and builder for a 6.9 megawatt (“MW”) Brooklyn Project in Nova Scotia, a community solar initiative set to power around 900 homes. The development is part of Canada’s first Community Solar Program (“CSP”) (https://ibn.fm/01vZx). SolarBank has considerable expertise in community solar development in the United States and it is now deploying that expertise in Canada where there remain significant government support and incentives for renewable energy projects.

The project is owned by AI Renewable Fund, which secured two of the three CSP contracts granted to date, totaling 6.5 MW AC. SolarBank will lead the engineering and construction effort in partnership with local firm Trimac Engineering. The total project cost is estimated at $13.9 million.

The Nova Scotia Community Solar Program is central to the province’s plan to reach 80% renewable energy by 2030 and achieve net-zero emissions by 2035. The program aims to add 100 MW of solar power to the grid, with community-based installations that allow residents and businesses to subscribe and receive credits on their electricity bills. Participants save roughly $0.02 per kilowatt-hour for energy generated, without the need to install their own solar panels.

Community solar projects such as Brooklyn are designed to democratize access to renewable energy. Renters and homeowners who are otherwise unable to deploy solar on their own property can benefit from shared clean energy infrastructure. As the developer, SolarBank will now proceed through the permitting phase and initiate technical work including interconnection studies with Nova Scotia Power Inc.

Construction is expected to begin in Spring 2026, with completion targeted for the summer. The Brooklyn site has a secured lease, enabling SolarBank and its partners to move forward with design and engineering in the coming months. This includes in-depth feasibility studies, finalization of the solar layout, and grid integration assessments.

Richard Lu, President and CEO of SolarBank, commented that the company’s long-standing experience in solar development positioned it well for projects under Nova Scotia’s CSP. “As the project developer, we are excited to work alongside our local partner Trimac Engineering and the province’s dedicated team to help bring clean, affordable energy to communities across Nova Scotia,” Lu said. “With over a decade of proven experience in solar development and operations—including community solar, commercial and industrial installations, and other government-led initiatives—SolarBank brings the expertise needed to the successful implementation of Nova Scotia’s Community Solar projects.”

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press release entitled “6.9 MW Brooklyn Project in Development by SolarBank in Nova Scotia” for additional details on the information, risks and assumptions.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in SolarBank Corp. SUUN | Leave a comment

MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Conference

Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Thursday, June 5 at 4 p.m. ET. The session will feature a fireside-style Q&A open to live audience questions, with 1×1 meetings available for qualified investors. A webcast of the presentation will be accessible post-event on Nutriband’s website and Channelchek.com, where it will remain archived for 90 days.

To view the full article, visit https://ibn.fm/WXEv5

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is an abuse-deterrent fentanyl patch incorporating its AVERSA(TM) abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. For more information about the company, visit www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Nutriband Inc. NTRB | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Launches Commercial Availability of Advantage2(TM) Quantum System

  • Advantage2 offers a 4,400+ qubit processor with improved coherence and connectivity
  • The system targets real-world applications in optimization, materials simulation, and AI, and features a 75% reduction in noise and a 40% energy scale increase over the predecessor Advantage(TM) quantum system
  • Customers can access the Advantage2 system via D-Wave’s Leap(TM) cloud service or deploy it on-premises
  • The Advantage2 system represents a remarkable achievement in helping customers realize value from quantum computing right now, said CEO Dr. Alan Baratz

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has officially announced the general availability of its Advantage2 annealing quantum computing system. The launch marks the debut of what the company calls its most performant system yet, delivering energy-efficient, scalable quantum processing capable of tackling problems beyond the capabilities of classical computers (https://ibn.fm/OrjxO).

The Advantage2 system features more than 4,400 qubits and is available through D-Wave’s Leap real-time quantum cloud service and for on-premises deployment by enterprises and research institutions. The system is engineered to address complex optimization, simulation, and machine learning challenges across various sectors.

One of the central advances in Advantage2 lies in its processor architecture. Built on Zephyr(TM) topology, this is D-Wave’s most advanced processor to date, increasing qubit connectivity to 20-way, enabling more complex problems to be embedded directly into the system. It also features double the coherence time of previous generations, a factor that contributes to faster time-to-solution. Additionally, the system reports a 75% reduction in noise and a 40% increase in energy scale, both of which enhance the quality and consistency of quantum calculations.

D-Wave also emphasized the system’s readiness for production use. According to the company, Advantage2 consumes only 12.5 kilowatts of electricity, consistent with D-Wave’s prior five generations of annealing quantum computing systems, an important consideration for businesses looking to manage operational costs while scaling up computational capabilities.

D-Wave’s Leap quantum cloud platform, which now offers access to the Advantage2 system, is accessible in over 40 countries and includes support for hybrid solvers capable of handling problems involving up to two million variables and constraints. This functionality aims to support businesses running large-scale optimization tasks in fields such as logistics, communications, finance, and manufacturing. Since June 2022, more than 20 million customer problems have been submitted, with usage increasing by 134% over the past six months, according to D-Wave.

At Los Alamos National Laboratory, scientists are using D-Wave’s technology to explore quantum applications in condensed matter theory and magnetic materials. “We currently use the Advantage2 prototype system, which has yielded a variety of interesting technical results that are currently being prepared for peer review. The team is eager to work on the full-scale Advantage2 system to further this research,” said Carleton Coffrin, a senior scientist at the lab.

In the private sector, Davidson Technologies is set to host an Advantage2 system at its Alabama headquarters, focusing on mission-critical and national security-related quantum applications. Davidson Technologies President and CEO Dale Moore stated: “We believe this system offers an important new pathway for the development of quantum optimization applications designed to support mission-critical challenges and national security-focused quantum research.”

Japan Tobacco’s Central Pharma Research Institute has used the Advantage2 system in a proof-of-concept project combining quantum computing with AI for drug discovery. “The impact of bringing quantum together with AI could drive new breakthroughs in life sciences, as demonstrated in our recent proof of concept. The project revealed that D-Wave’s Advantage2 quantum systems can deliver high quality, low energy samples that could drive enhanced performance in generative AI architectures,” said Dr. Masaru Tateno, Chief Scientific Officer of Central Pharma Research Institute.

Also, the Jülich Supercomputing Centre at Forschungszentrum Jülich in Germany plans to upgrade its current Advantage system to an Advantage2 system and connect it with JUPITER, Europe’s only exascale-class supercomputer, for research in AI and quantum optimization applications.

Dr. Alan Baratz, D-Wave’s CEO, described the Advantage2 commercial release as a pivotal step in the company’s mission to deliver commercially viable quantum computing.

“Today marks a significant milestone not just for D-Wave, but for the quantum computing industry as a whole, as we bring to market our sixth-generation quantum computer, a system so powerful that it can solve hard problems outside the reach of one of the world’s largest exascale GPU-based classical supercomputers,” said Dr Baratz. “It’s an engineering marvel, with substantial technical advancements that highlight D-Wave’s progress in scaling quantum technology to meet industry demands for growing computational processing power while maintaining energy efficiency. We’re helping customers realize value from quantum computing right now, and the Advantage2 system represents a remarkable achievement in delivering on that mission.”

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our quantum computers, the world’s largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our quantum systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Secures Definitive $18.4M DoD Award to Build First Commercial RapidSX(TM) System

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) has finalized the contract for an $18.4 million award from the U.S. Department of Defense to construct its first commercial-scale RapidSX(TM) rare earth separation system and infrastructure at the Strategic Metals Complex (SMC) in Alexandria, Louisiana. This brings total non-repayable funding under Ucore’s existing OT Agreement to $22.4 million. The funds will support engineering, permitting, and construction of a RapidSX(TM) machine and supporting systems capable of processing individual rare earth oxides starting in the second half of 2026. A groundbreaking ceremony was held May 29 with local, state, and federal leaders in attendance. The facility is located in a Foreign Trade Zone, providing logistical and tax advantages. Ucore also continues to receive support from Canadian federal and provincial programs, advancing its goal to establish a domestic supply chain for critical minerals.

To view the full press release, visit https://ibn.fm/PCub9

About Ucore Rare Metals Inc.

Ucore is focused on rare- and critical-metal resources, extraction, beneficiation, and separation technologies with the potential for production, growth, and scalability. Ucore’s vision and plan is to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry.

Through strategic partnerships, this plan includes disrupting the People’s Republic of China’s control of the North American REE supply chain through the near-term establishment of a heavy and light rare-earth processing facility in the U.S. State of Louisiana, subsequent Strategic Metal Complexes in Canada and Alaska and the longer-term development of Ucore’s 100% controlled Bokan-Dotson Ridge Rare Heavy REE Project on Prince of Wales Island in Southeast Alaska, USA.

Ucore is listed on the TSXV under the trading symbol “UCU” and in the United States on the OTC Markets’ OTCQX(R) Best Market under the ticker symbol “UURAF.”

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment

MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development

Nutriband (NASDAQ: NTRB) reported first-quarter revenue of $667,000, a 63% year-over-year increase driven by expanded kinesiology tape production through its Pocono Pharma subsidiary and growing retail presence at Target, Walmart, Walgreens, and CVS. The company continues to prioritize shareholder value by scaling Pocono’s output through penetration pricing strategies while advancing development of AVERSA Fentanyl, an abuse-deterrent transdermal opioid patch. A newly formalized partnership with Kindeva Drug Delivery will support shared development costs in exchange for milestone payments as AVERSA moves toward regulatory approval. The product is projected to reach peak U.S. sales of $80 million to $200 million annually.

To view the full article, visit https://ibn.fm/ZgtNv

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is an abuse-deterrent fentanyl patch incorporating its AVERSA(TM) abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. For more information about the company, visit www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Nutriband Inc. NTRB | Leave a comment

MissionIRNewsBreaks – Innovation in Motion: Massimo Group (NASDAQ: MAMO) Launches Fully Digital Retail Platform 

Massimo Group (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the company’s national sales footprint. “The platform enables customers to complete transactions online, including financing, titling, and checkout, providing a fully digital experience,” reads a recent article discussing the launch. “Massimo expects this shift to unlock greater scalability, reduce sales friction, and drive a significant increase in annual revenue.”

To view the full article, visit https://ibn.fm/3peWu

About Massimo Group

Massimo Group is a manufacturer and distributor of powersports vehicles and pontoon boats. Founded in 2009, Massimo Motor believes it offers some of the most value packed UTVs, off-road, and on-road vehicles in the industry. The company’s product lines include a wide selection of farm and ranch tested utility UTVs, recreational ATVs, and Americana style mini-bikes. Massimo Marine manufactures and sells pontoon and tritoon boats with a dedication to innovative design, quality craftsmanship, and great customer service. Massimo Group is also developing electric versions of UTVs, golf-carts and pontoon boats. The company’s 376,000 square foot factory is in the heart of the Dallas / Fort Worth area of Texas in the city of Garland. For more information, visit massimomotor.com and massimomarine.com.

NOTE TO INVESTORS: The latest news and updates relating to MAMO are available in the company’s newsroom at https://ibn.fm/MAMO

About Fintech Ecosystem Development Corp.

Fintech Ecosystem Development is a special purpose acquisition company formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector. The company is sponsored by Revofast LLC and the management team led by CEO, president and founder Dr. Saiful Khandaker and a group of experienced fintech business and technology innovators. For more information about the company, please visit www.FintechEcosys.com.

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Massimo Group. MAMO | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q1 Revenue Growth Driven by CDMO Contracts, Net Loss Narrows

Scinai Immunotherapeutics (NASDAQ: SCNI) reported first quarter 2025 financial results, posting $586K in revenue, up from zero in the prior-year period, reflecting continued expansion of its CDMO business. R&D expenses declined to $1.3M from $1.6M, while marketing, general and administrative costs held steady at $500K. The company recorded a $1.6M net loss, improving from a $2.2M loss in Q1 2024, aided by reduced R&D and financial expenses. Cash and equivalents totaled $1M at quarter-end, down from $2M a year earlier.

To view the full press release, visit https://ibn.fm/yofBq

About Scinai Immunotherapeutics Ltd.

Scinai is a biopharmaceutical company with two complementary business units. One is focused on in-house development of inflammation and immunology (“I&I”) biological therapeutic products beginning with an innovative, de-risked pipeline of nanosized VHH antibodies (“NanoAbs”) targeting diseases with large unmet medical needs. The second business unit is a boutique CDMO providing biological drug development, analytical methods development, clinical GMP manufacturing, and preclinical and clinical trial design and execution services to early stage biotech companies. For more information, visit the company’s website at www.Scinai.com.

NOTE TO INVESTORS: The latest news and updates relating to SCNI are available in the company’s newsroom at https://ibn.fm/SCNI

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment